Michael Moses is a finance and strategy executive with experience in public company reporting, restructuring, and capital raising. He leads Allied Corp., a pharmaceutical company that was formerly publicly listed, managing a team of over 50 people across Latin America, North America, and Europe. In this role, he has driven the company’s operational and financial restructuring, strengthened governance and secured funding to support international growth. While overseeing all financial planning and reporting, he also led the commercialization of Allied’s products, securing over $15 million in commercial contracts.

Previously, Michael founded and scaled a B2B data and digital marketing business focused on ESG and social impact, and served as a strategic consultant at Parkdale Investments, advising on strategic planning, regulatory matters, and operational improvements across wealth management and investment solutions. He holds a Master’s degree in Electrical and Electronic Engineering with Management from Imperial College London.